Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Case Comprehensive Cancer Center
Zhejiang University
Centre Oscar Lambret
Roswell Park Cancer Institute
University of Miami
Mayo Clinic
Fred Hutchinson Cancer Center
Fondazione del Piemonte per l'Oncologia
The Methodist Hospital Research Institute
M.D. Anderson Cancer Center
University of Alabama at Birmingham
The Netherlands Cancer Institute
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of California, Davis
Dana-Farber Cancer Institute
Catholic University of the Sacred Heart
University of California, Irvine
University of Wisconsin, Madison
WellSpan Health
Nordic Society of Gynaecological Oncology - Clinical Trials Unit
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Dana-Farber Cancer Institute
University of Miami
University of Oklahoma
Hospices Civils de Lyon
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
Essen Biotech
Essen Biotech
Azienda Ospedaliero-Universitaria di Parma
Ohio State University Comprehensive Cancer Center
North Eastern German Society of Gynaecological Oncology
Ohio State University Comprehensive Cancer Center
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
University Hospital Tuebingen
Mayo Clinic
Abramson Cancer Center at Penn Medicine
Institut Curie
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Mayo Clinic
Memorial Sloan Kettering Cancer Center
Dartmouth-Hitchcock Medical Center
University of Nebraska
M.D. Anderson Cancer Center
Colorado State University
Hospices Civils de Lyon
Memorial Sloan Kettering Cancer Center
Imperial College London